当前位置: 首页 > 期刊 > 《中国医学创新》 > 2025年第11期
编号:2317378
活血复元胶囊联合地舒单抗治疗绝经后骨质疏松性肋骨骨折的临床效果
http://www.100md.com 2025年6月4日 中国医学创新 2025年第11期
     Clinical Effect of Huoxue Fuyuan Capsules Combined with Denosumab in the Treatment of Postmenopausal Osteoporotic Rib Fractures/YANG Panpan, HU Jun, ZHANG Bin, YE Xiaoqing, TAN Rongzhen, ZHU Ying, YUAN Zhong. //Medical Innovation of China, 2025, 22(11): 021-025

    [Abstract]Objective: To investigate the effect of Huoxue Fuyuan Capsules combined with Denosumab in the treatment of postmenopausal patients with osteoporotic rib fractures.Method: A total of 180 postmenopausal patients with osteoporotic rib fractures admitted to Nanchang Hongdu Hospital of TCM from January 2022 to May 2023 were randomly divided into three groups,with 60 patients ineach group.The control group 1 was treated with HuoxueFuyuan Capsules,the control group 2 was treated with Denosumab, and theobservation group was treated with Huoxue Fuyuan Capsules combined with Denosumab.Allthree groups were treated for one year. The pain degree,clinicalindicators,bone mineral density,four items ofosteoporosis and imaging examination were compared among the three groups.Result:Thevisualanalog scale(VAS)scores of theobservation groupafter 6 ......

您现在查看是摘要页,全文长 13071 字符